DE LAURENZI, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 240
EU - Europa 94
AS - Asia 48
Continente sconosciuto - Info sul continente non disponibili 1
Totale 383
Nazione #
US - Stati Uniti d'America 240
VN - Vietnam 30
IT - Italia 29
DE - Germania 16
SE - Svezia 11
UA - Ucraina 10
IE - Irlanda 9
FI - Finlandia 8
SG - Singapore 8
CN - Cina 6
BE - Belgio 5
GB - Regno Unito 4
IR - Iran 3
AZ - Azerbaigian 1
EU - Europa 1
GR - Grecia 1
RU - Federazione Russa 1
Totale 383
Città #
Chandler 39
Dong Ket 30
Fairfield 28
Woodbridge 18
Cambridge 13
Wilmington 11
Ashburn 10
Jacksonville 10
Dublin 9
Seattle 9
Houston 8
Boardman 7
Falkenstein 7
Helsinki 7
Lawrence 6
Princeton 6
Brussels 5
Ann Arbor 4
Singapore 4
London 3
Munich 3
San Diego 3
Scauri 3
Castelfranco Emilia 2
Genova 2
Newark 2
Pescara 2
Shanghai 2
Zanjan 2
Aquila 1
Athens 1
Baku 1
Espoo 1
Frankfurt am Main 1
Gunzenhausen 1
L'aquila 1
Leawood 1
Los Angeles 1
L’Aquila 1
New York 1
Nuremberg 1
San Mateo 1
Scandicci 1
Zhuhai 1
Totale 270
Nome #
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 99
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 64
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 60
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 57
Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma 48
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 43
Advances in pharmacotoxicological investigation of Sudden Cardiac Death: Literature review and novel perspectives 21
Totale 392
Categoria #
all - tutte 2.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.756


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/2021138 0 11 4 14 8 16 5 12 17 4 13 34
2021/202274 9 3 0 4 4 7 3 6 3 4 30 1
2022/202390 12 9 2 8 11 11 0 12 16 2 6 1
2023/202424 5 2 4 3 0 0 1 0 0 0 2 7
2024/202559 16 13 17 10 3 0 0 0 0 0 0 0
Totale 392